AvePoint [AVPT] vs Oracle [ORCL] Detailed Stock Comparison
AvePoint
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AvePoint wins in 7 metrics, Oracle wins in 11 metrics, with 0 ties. Oracle appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AvePoint | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 57.48 | N/A |
| Price-to-Book Ratio | 6.83 | 34.32 | AvePoint |
| Debt-to-Equity Ratio | 4.24 | 519.59 | AvePoint |
| PEG Ratio | 62.30 | 34.92 | Oracle |
| EV/EBITDA | 89.70 | 34.09 | Oracle |
| Profit Margin (TTM) | -2.26% | 21.68% | Oracle |
| Operating Margin (TTM) | 6.95% | 32.48% | Oracle |
| EBITDA Margin (TTM) | 6.95% | 32.48% | Oracle |
| Return on Equity | -2.40% | 82.38% | Oracle |
| Return on Assets (TTM) | 2.59% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $84.64M | $-394.00M | AvePoint |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 42.45% | 89.35% | Oracle |
| Price-to-Sales Ratio (TTM) | 8.14 | 12.24 | AvePoint |
| Enterprise Value | $2.63B | $800.62B | Oracle |
| EV/Revenue Ratio | 7.04 | 13.95 | AvePoint |
| Gross Profit Margin (TTM) | 74.32% | 70.19% | AvePoint |
| Revenue per Share (TTM) | $2 | $21 | Oracle |
| Earnings per Share (Diluted) | $-0.13 | $4.35 | Oracle |
| Beta (Stock Volatility) | 1.35 | 1.43 | AvePoint |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AvePoint vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AvePoint | 2.79% | -20.17% | -23.08% | -17.64% | -26.93% | -13.78% |
| Oracle | 0.26% | 2.30% | 6.63% | 66.37% | 39.76% | 50.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AvePoint | 42.45% | 185.46% | 40.22% | 46.52% | 46.52% | 46.52% |
| Oracle | 89.35% | 215.92% | 361.35% | 534.48% | 1,003.49% | 1,780.08% |
Performance & Financial Health Analysis: AvePoint vs Oracle
| Metric | AVPT | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $3.04B | $702.35B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 1,777,230 | 10,188,060 |
| 90 Day Avg. Volume | 1,365,693 | 12,616,010 |
| Last Close | $14.73 | $250.05 |
| 52 Week Range | $9.96 - $20.25 | $118.86 - $260.87 |
| % from 52W High | -27.24% | -4.15% |
| All-Time High | $20.25 (May 12, 2025) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -27.26% | -4.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.11% |
| Quarterly Earnings Growth | 0.25% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.22% |
| Operating Margin (TTM) | 0.07% | 0.32% |
| Return on Equity (TTM) | -0.02% | 0.82% |
| Debt to Equity (MRQ) | 4.24 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.10 | $7.29 |
| Cash per Share (MRQ) | $2.03 | $3.99 |
| Operating Cash Flow (TTM) | $85.75M | $20.82B |
| Levered Free Cash Flow (TTM) | $84.58M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: AvePoint vs Oracle
| Metric | AVPT | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 57.48 |
| Forward P/E | 62.30 | 34.92 |
| PEG Ratio | 62.30 | 34.92 |
| Price to Sales (TTM) | 8.14 | 12.24 |
| Price to Book (MRQ) | 6.83 | 34.32 |
| Market Capitalization | ||
| Market Capitalization | $3.04B | $702.35B |
| Enterprise Value | $2.63B | $800.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.04 | 13.95 |
| Enterprise to EBITDA | 89.70 | 34.09 |
| Risk & Other Metrics | ||
| Beta | 1.35 | 1.43 |
| Book Value per Share (MRQ) | $2.10 | $7.29 |
Financial Statements Comparison: AvePoint vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AVPT | ORCL |
|---|---|---|
| Revenue/Sales | $93.06M | $15.90B |
| Cost of Goods Sold | $23.90M | $4.74B |
| Gross Profit | $69.17M | $11.16B |
| Research & Development | $12.69M | $2.65B |
| Operating Income (EBIT) | $3.29M | $5.19B |
| EBITDA | $2.72M | $7.00B |
| Pre-Tax Income | $4.87M | $4.15B |
| Income Tax | $1.31M | $725.00M |
| Net Income (Profit) | $3.57M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AVPT | ORCL |
|---|---|---|
| Cash & Equivalents | $351.48M | $10.79B |
| Total Current Assets | $446.64M | $24.58B |
| Total Current Liabilities | $208.21M | $32.64B |
| Long-Term Debt | $11.65M | $96.83B |
| Total Shareholders Equity | $361.45M | $20.97B |
| Retained Earnings | $-515.47M | $-15.48B |
| Property, Plant & Equipment | $23.77M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AVPT | ORCL |
|---|---|---|
| Operating Cash Flow | $-1.94M | $5.93B |
| Capital Expenditures | $-1.51M | N/A |
| Free Cash Flow | $-1.47M | $-2.92B |
| Debt Repayment | $-2,000 | $-6.07B |
| Common Stock Repurchase | $-11.91M | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AVPT | ORCL |
|---|---|---|
| Shares Short | 5.31M | 20.68M |
| Short Ratio | 4.19 | 1.27 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 1,777,230 | 10,188,060 |
| Average Daily Volume (90 Day) | 1,365,693 | 12,616,010 |
| Shares Outstanding | 194.07M | 2.81B |
| Float Shares | 124.98M | 1.64B |
| % Held by Insiders | 0.33% | 0.42% |
| % Held by Institutions | 0.62% | 0.45% |
Dividend Analysis & Yield Comparison: AvePoint vs Oracle
| Metric | AVPT | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |